These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22875905)

  • 21. Neonatal varicella: varicella zoster immunoglobulin (VZIG) does not prevent disease.
    Reynolds L; Struik S; Nadel S
    Arch Dis Child Fetal Neonatal Ed; 1999 Jul; 81(1):F69-70. PubMed ID: 10375368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of Varitect in the prevention of diseases in children caused by varicella-zoster viruses].
    Bartosová D; Wiedermannová D
    Cesk Pediatr; 1993 May; 48(5):275-7. PubMed ID: 8374966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin prophylaxis for infants exposed to varicella in a neonatal unit.
    Patou G; Midgley P; Meurisse EV; Feldman RG
    J Infect; 1990 May; 20(3):207-13. PubMed ID: 2341729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards evidence based medicine for paediatricians. How effective is varicella-zoster immunoglobulin (VZIG) in preventing chickenpox in neonates following perinatal exposure?
    Tebruegge M; Pantazidou A; Curtis N
    Arch Dis Child; 2009 Jul; 94(7):559-61. PubMed ID: 19542068
    [No Abstract]   [Full Text] [Related]  

  • 25. Preventing congenital varicella syndrome with immunization.
    Sauerbrei A
    CMAJ; 2011 Feb; 183(3):E169-70. PubMed ID: 21262940
    [No Abstract]   [Full Text] [Related]  

  • 26. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(8):209-10. PubMed ID: 16511443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues.
    Weinstock DM; Boeckh M; Boulad F; Eagan JA; Fraser VJ; Henderson DK; Perl TM; Yokoe D; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2004 Jul; 25(7):603-8. PubMed ID: 15301035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe chickenpox during treatment with corticosteroids. At what age should varicella-zoster immunoglobulin be given?
    Buss P
    BMJ; 1995 Feb; 310(6975):327; author reply 328. PubMed ID: 7866184
    [No Abstract]   [Full Text] [Related]  

  • 29. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.
    McKendrick MW; Lau J; Alston S; Bremner J
    J Infect; 2007 Jul; 55(1):64-7. PubMed ID: 17418420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(12):212. PubMed ID: 22456121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Postexposure prophylaxis in daily clinical practice].
    Küpper MF; Stellbrink HJ; Kern WV; Müller MC
    Dtsch Med Wochenschr; 2015 Apr; 140(7):485-8. PubMed ID: 25826030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The protective value of varicella-zoster immunoglobulin in the hospital environment].
    Puvacić Z; Naumović M; Puvacić B; Hadimujić I; Prekajski D; Bosković R
    Med Arh; 1983; 37(3):139-42. PubMed ID: 6400849
    [No Abstract]   [Full Text] [Related]  

  • 33. Management and outcome of a varicella exposure in a neonatal intensive care unit: lessons for the vaccine era.
    Kellie SM; Makvandi M; Muller ML
    Am J Infect Control; 2011 Dec; 39(10):844-8. PubMed ID: 21600672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fifteen-minute consultation: Prevention and treatment of chickenpox in newborns.
    Holland C; Sadarangani M
    Arch Dis Child Educ Pract Ed; 2020 Feb; 105(1):24-30. PubMed ID: 31122930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zoster immune plasma prophylaxis of varicella: a follow-up report.
    Balfour HH; Groth KE
    J Pediatr; 1979 May; 94(5):743-6. PubMed ID: 221631
    [No Abstract]   [Full Text] [Related]  

  • 36. Varicella-zoster immune globulin for the prevention of chickenpox. Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control.
    Ann Intern Med; 1984 Jun; 100(6):859-65. PubMed ID: 6326634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Varicella-zoster immune globulin--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Jan; 30(2):15-6, 21-3. PubMed ID: 6789088
    [No Abstract]   [Full Text] [Related]  

  • 38. Varicella-zoster immune globulin.
    Med Lett Drugs Ther; 1982 May; 24(610):51-3. PubMed ID: 7078520
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention and treatment of varicella-zoster virus infection.
    Gershon AA
    Pediatr Infect Dis; 1984; 3(3 Suppl):S34-6. PubMed ID: 6204323
    [No Abstract]   [Full Text] [Related]  

  • 40. Varicella-related deaths among adults--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 May; 46(19):409-12. PubMed ID: 9162840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.